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Last year, Gerdes and colleagues published a paper (1) describing experiments thatfailed to support earlier work from their group (2, 3) which had implicated 10 type
II toxin-antitoxin (TA) systems in the formation of antibiotic-tolerant Escherichia coli
K-12 persister cells. The problem apparently arose as a result of contamination by and
activation of the cryptic bacteriophage 80 in mutant strains lacking TA genes. A more
recent paper by Goormaghtigh et al. (4) confirms and extends this reappraisal by
providing evidence that an independently constructed E. coli K-12 mutant strain lacking
the 10 type II TAs and free of phage contamination produced levels of persisters similar
to those of wild-type bacteria after exposure to antibiotics (4). In addition, this work
questions the validity of TA::green fluorescent protein (GFP) transcriptional reporter
fusions (3). Since the possible link between TA systems and the persister phenotype is
being studied in many laboratories, these corrections are both important and salutary.
However, we highlight what seem to us to be some overstatements and factual
inaccuracies in the highly critical paper of Goormaghtigh et al. (4).
First, the authors state that “results obtained with an independently constructed
10TA strain do not support a role for TA systems in persistence. . . .” However, their
polymutant strain was analyzed only at mid-exponential growth phase in “optimally
balanced” medium. It is not clear whether the relevant TA systems are physiologically
active in these conditions, and the mutant needs to be subjected to further phenotypic
analysis (e.g., following physiological stress) before general conclusions can be drawn
about the involvement of TA systems in E. coli K-12 persister formation. It is noteworthy
that a study from another group showed that a strain lacking one of the type II toxin
genes mutated in the 10TA strain (yafQ) had a very strong defect in antibiotic
tolerance when grown as a biofilm (5).
Second, the authors state that “The model linking TA systems and persistence to
antibiotics had a major impact in the microbiology community as a whole. Recently,
this model was invalidated. . . .” The purported invalidation relates only to nonstressed
E. coli K-12. Evidence for the involvement of TA systems in persister formation has been
obtained for several other bacteria, including uropathogenic E. coli (6), Burkholderia (7),
and Salmonella (8–10).
Third, the authors state that “The model linking TA modules and persistence initially
stemmed from observations made by the K. Gerdes lab that successive deletions of 10
type II TA systems. . . progressively decreased the level of persistence to antibiotics.” In
fact, this model goes back over 30 years to a phenotypic analysis of the hipA7 mutant
that displays enhanced levels of persister formation (11). Furthermore, forced overex-
pression of the toxin RelE (12) or MazF (13, 14) in E. coli led to significant increases in
persister cells. These papers therefore provide additional evidence linking TA systems
to persisters.
Scientific research is inherently error-prone: in experimental design, execution, and
interpretation. What matters is not error per se but recognition of it. We commend Kenn
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Gerdes and his group for their scientific probity in setting the record straight (1, 15).
Clearly, further work is needed to establish the relative contributions of TA systems to
persister formation in E. coli K-12 strains and other bacteria.
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